Long‐term outcomes and predictors of early response, late relapse, and survival for patients treated with bispecific LV20.19 CAR T‐cells
暂无分享,去创建一个
P. Hari | Bryon D Johnson | A. Szabo | N. Shah | M. Hamadani | T. Fenske | J. Zurko | K. Chaney | Huiqing Xu | Daniel Bucklan | Bryon D. Johnson